
SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

